Published 2014 | Version v1
Publication

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results.

Citation

An error occurred while generating the citation.

Additional details

Created:
April 14, 2023
Modified:
November 30, 2023